BioMarin Pharmaceutical
BMRN
#1718
Rank
ยฃ9.02 B
Marketcap
ยฃ46.59
Share price
-0.59%
Change (1 day)
15.77%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2026 (TTM): -ยฃ0.06429

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is -ยฃ0.06867. In 2025 the company made an earnings per share (EPS) of ยฃ1.39 a decrease over its 2024 EPS that were of ยฃ1.72.

EPS history for BioMarin Pharmaceutical from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.06429-104.63%
2025ยฃ1.39-19.11%
2024ยฃ1.72152.81%
2023ยฃ0.6815.79%
2022ยฃ0.59-319.62%
2021-ยฃ0.27-107.38%
2020ยฃ3.62-3485.71%
2019-ยฃ0.11-67.44%
2018-ยฃ0.33-34.85%
2017-ยฃ0.50-83.21%
2016-ยฃ3.00263.89%
2015-ยฃ0.8218.68%
2014-ยฃ0.69
2012-ยฃ0.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
ยฃ1.51-2,300.59%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ3.96 5,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ0.29 322.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01526-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08392 22.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ1.38-2,111.11%๐Ÿ‡บ๐Ÿ‡ธ USA